The Veteran's application to reopen his claim of entitlement to service connection for bilateral lower extremity peripheral neuropathy is granted. The Board also remanded the issues of service connection for bladder cancer and TDIU due to inextricably intertwined nature.
The deciding factor: The decision was not clear on the basis for granting or denying service connection, but it was noted that new evidence had been submitted which created a reasonable possibility of an allowance of the claim. The remand is due to the need for additional medical opinions regarding the Veteran's conditions and their relation to his military service.
- Claimed conditions
- bilateral lower extremity peripheral neuropathy, bladder cancer
- How they argued it
- Presumptive (no nexus needed)
- Exposure basis
- Agent Orange / herbicides
- Rating assigned
- None in this decision
- Decision date
- June 11, 2018
- Citation
- 18109863
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 18109863.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Veteran's TDIU was granted effective October 24, 2017. The attorney fees are eligible based on the past-due benefits awarded in the May 2021 rating decision.
- Remanded (sent back)
The Board has determined that additional medical opinions are needed to address the etiology of the Veteran's bilateral lower extremity and foot peripheral neuropathy, particularly in relation to herbicide agent exposure during service.
- Remanded (sent back)
The Board has identified errors in the rating decision and is remanding the case for further development to ensure all relevant evidence is considered.
- Dismissed
The Veteran's prostate and bladder cancer rating was reduced from 100% to 40%, effective December 1, 2025. The Veteran withdrew his appeal at a Board hearing held in April 2026.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.